IHU ICAN, a center of scientific excellence against cardiometabolic diseases
IHU ICAN institutional video: who are we? (English version)
Heading toward 2026 for IHU ICAN: research is accelerating!
France 2030: essential support for the health of tomorrow in cardiometabolism
National Cardiometabolic Diseases Week: everyone is concerned!
What is an IHU? (English version)
Cardiometabolism, a public health challenge
Cardiometabolic diseases explained by Prof. Hatem
“1 million hospitalizations are due to cardiometabolic diseases” | Dr Caroline Semaille
“Cardiometabolic diseases concern everyone, at any time” | Prof. Stéphane Hatem
The French Health Insurance system facing the explosion of cardiometabolic diseases | Dr Catherine Grenier
Cardiometabolic diseases: “diagnostic tools are improving” | Prof. Etienne Gayat
“What dialogue between organs? Liver, heart, kidney, adipose tissue, brain…” | Prof. Vlad Ratziu
Focus on major projects
The ICONIC project: the first cardiac and liver imaging atlas in the general population
The MAESTRIA project: artificial intelligence serving innovation (English version)
The PEGASE project: a major breakthrough in heart transplantation
Technological platforms
Discover the installation of the research MRI on the ICAN Imaging platform
ICAN BioCell Human Liver Biology platform: research on chronic liver diseases
ICAN BioCell iPS platform: production and genetic modification of iPS cells
Replay of our conferences
Conference at the Ministry of Health “Prevention of cardiometabolic diseases”: PART 1/2
Conference at the Ministry of Health “Prevention of cardiometabolic diseases”: PART 2/2
Conference at the French National Academy of Medicine “Cardiometabolic diseases: everyone is concerned”: PART 1/2
Conference at the French National Academy of Medicine “Cardiometabolic diseases: everyone is concerned”: PART 2/2
Conference at the Council of State “AI and big data”: PART 1/2
Conference at the Council of State “AI and big data”: PART 2/2
Support research with us
Why support IHU ICAN?
Donor testimonial: TRIOMPHE DU COEUR supports IHU ICAN
“Biomedical research must be funded at a level very different from the current one” | Prof. Boitard
Cardiovascular diseases
Cardiac rehabilitation: what role does physical activity play?
Coronary CT scan: how does the examination take place?
Cardiomyopathies: how can genetic diagnosis be improved?
Hereditary heart diseases: a project to support adolescents and young adults
Cardio-immunology: what advances in research?
Computational Fluid Dynamics Analysis of Left Atrial Blood Flow in Patients with Atrial Fibrillation (English version)
MASH (metabolic steatohepatitis)
REPLAY: Webinar | MASH (“fatty liver disease”), multidisciplinary care is essential
The MASH clinic: a unique care pathway in France against “fatty liver disease”
MASLD: what role do mitochondrial dysfunctions play in metabolic fatty liver disease?
Obesity and nutrition
REPLAY: Webinar | Obesity: patient testimony, care management, and metabolic risks
What impact does maternal obesity have on postnatal cardiac development? (OB-MAT project)
“Medications against obesity are a revolution” | Prof. Judith Aron-Wisnewsky
Obesity: “for our children, prevention and protection are imperative” | Anne-Sophie Joly
Overweight and obesity: how can we avoid other cardiometabolic diseases?
Nutrition and cardiometabolism: 5 questions for a nutritionist
Diabetes
Diabetes: “the level of prescription of medications is insufficient” | Dr Jean-François Thébaut
Living with diabetes: testimony from a patient with type 1 diabetes
Type 2 diabetes: causes, diagnosis, treatments
Type 1 diabetes: causes, diagnosis, treatments
Microbiota, bariatric surgery: what impacts on type 2 diabetes?
The diabetic foot: complications and management
What care pathway for type II diabetes?
Climbing a 7,000 m summit: the ambitious challenge of a patient with diabetes
Familial hypercholesterolemia
REPLAY: Webinar | Homozygous and heterozygous familial hypercholesterolemia
IDEAL-HFHo, a research project against a rare genetic disease: homozygous FH
Where does research on familial hypercholesterolemia stand?
Interview with the ANHET association for FH Week 2022
What is hypercholesterolemia?
Training / education
Launch of the University Diploma “Health and Cardiometabolic Diseases” (Prof. Vlad Ratziu & Prof. Stéphane Hatem)
Doctoral student or post-doc? Join the IHU ICAN Summer Camp! (English version)
Lipidomics as a powerful tool for clinical studies (English version)
Votre soutien est essentiel pour accélérer la recherche !
Pour en savoir plus, votre contact privilégié :
Francine Trocmé
Direction communication et mécénat
06 81 64 97 88 – f.trocme@ihuican.org
“`







